C07D 221/08
Aza-anthracenes
C07D221/08 (Aza-anthracenes) appears on 133 US grants and 118 published applications in this corpus.
Search patents in C07D- Granted patents
- 133
- Published applications
- 118
- Assignees
- 77
- Inventors
- 287
- Latest grant
- 25 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 4 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 5 | 0 |
| 1997 | 4 | 0 |
| 1998 | 6 | 0 |
| 1999 | 4 | 0 |
| 2000 | 2 | 0 |
| 2001 | 4 | 3 |
| 2002 | 0 | 6 |
| 2003 | 6 | 2 |
| 2004 | 4 | 10 |
| 2005 | 4 | 3 |
| 2006 | 2 | 6 |
| 2007 | 0 | 4 |
| 2008 | 3 | 5 |
| 2009 | 4 | 6 |
| 2010 | 6 | 3 |
| 2011 | 5 | 6 |
| 2012 | 5 | 3 |
| 2013 | 4 | 5 |
| 2014 | 4 | 4 |
| 2015 | 4 | 2 |
| 2016 | 2 | 4 |
| 2017 | 3 | 3 |
| 2018 | 2 | 7 |
| 2019 | 5 | 4 |
| 2020 | 6 | 10 |
| 2021 | 6 | 5 |
| 2022 | 5 | 5 |
| 2023 | 2 | 1 |
| 2024 | 3 | 6 |
| 2025 | 5 | 3 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-g]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline-6,7-diol25 Nov 2025US 12,479,801 B2H. Lundbeck A.S.
- Catecholamine carbamate prodrugs for use in the treatment of parkinson's disease26 Aug 2025US 12,398,106 B2H. Lundbeck A.S.
- Catecholamine prodrugs for use in the treatment of Parkinson's disease19 Aug 2025US 12,391,650 B2H. Lundbeck A.S.
- Catecholamine prodrugs for use in the treatment of Parkinson's diseases3 Jun 2025US 12,319,710 B2H. Lundbeck A.S.
- Light emission material and organic electroluminescence device including the same1 Apr 2025US 12,268,088 B2Samsung Display Co., Ltd.
- Process for the manufacturing of (6ar,10ar)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4',5':5,6]benzo[1,2-g]quinoline and (4ar,10ar)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline-6,7-diol23 Jul 2026US 2026/0209181 A1H. Lundbeck A.S.
- Anticancer drug conjugates4 Jun 2026US 2026/0151413 A1Ariel Scientific Innovations Ltd.
- Novel ras inhibitors27 Nov 2025US 2025/0360124 A1
- Novel esters of 1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydrobenzo[g]quinolin-6-ol compounds and uses thereof11 Sep 2025US 2025/0282732 A1
- Novel 1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydrobenzo[g]quinolin-6-ol compounds and uses thereof11 Sep 2025US 2025/0282733 A1
Most cited
By later US patents
- Nitrogen-containing heteroaryl compounds and methods of use thereof60US 7,323,475 B2FibroGen, Inc. · 2008
- Pyridine anchors for HMG-CoA reductase inhibitors54US 5,506,219 AE. R. Squibb & Sons, Inc. · 1996
- Quinoline and pyridine anchors for HMG-CoA reductase inhibitors48US 5,691,322 AE. R. Squibb & Sons, Inc. · 1997
- Opiate compounds, methods of making and methods of use43US 6,593,348 B2Research Triangle Institute · 2003
- Extended rhodamine compounds useful as fluorescent labels41US 6,248,884 B1The Perkin-Elmer Corporation · 2001